White House rule would expand coverage of anti-obesity drugs
The Congressional Budget Office estimated in October that a policy authorizing Medicare to cover these drugs would increase federal spending by about $35 billion between 2026-2034.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.